Anxiety disorders affect as many as 30% of children and adolescents, and the children of parents with an anxiety disorder have a higher risk of developing an anxiety disorder than the children of parents [...]
Commonly Used Screening Tools May Not Identify Women with Perinatal Anxiety Disorders In 2015, the American College of Obstetricians and Gynecologists issued a committee opinion recommending that clinicians screen patients at least once during [...]
Maternal Anxiety and Adverse Perinatal Outcomes: Why We Need to Screen Women for Anxiety During Pregnancy
When providing information to patients regarding the use of medications during pregnancy, one key element of the decision-making process is an appraisal of the risks associated with untreated psychiatric illness in the mother. While there [...]
Anxiety disorders affect nearly 1 in 5 adults in the United States, and women are about twice as likely as men to suffer from an anxiety disorder at some point in their lifetime. According to [...]
According to a recent meta-analysis published in the Journal of Clinical Psychiatry, one in five pregnant women experience at least one type of anxiety disorder. While this may be surprising to some, anybody who works [...]
New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy
Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester. Anxiety during pregnancy is not necessarily a benign event. Various studies indicate [...]
Cognitive-behavioral therapy (CBT) is well-established as a treatment for anxiety disorders; however, few studies have examined the efficacy of CBT specifically tailored to address perinatal anxiety. A recent pilot study has explored the use of [...]
About 15% of women experience either anxiety or depressive symptoms during pregnancy. While we have data to support the reproductive safety of various antidepressant and anxiolytic medications, our data regarding the effects of these medications [...]
Given the prevalence of postpartum OCD and obsessive symptoms in women with postpartum depression, we should devote more time to this topic. This is an informative and well-written article by Alice Wolton on postpartum OCD in Forbes. In this piece, she mentions a recent study from Timpano and colleagues at the University of Miami where cognitive behavioral therapy (CBT) was used to prevent postpartum OCD.
Few studies have focused on anxiety disorders in the perinatal period. While various studies have measured levels of anxiety or distress during pregnancy, most studies have relied upon self-report questionnaires to assess for anxiety. In contrast, few studies have used standardized diagnostic criteria to determine the prevalence of anxiety disorders in pregnant populations. In a recent study, Buist and colleagues studied the prevalence and course of generalized anxiety disorder (GAD) in a prospectively ascertained population of pregnant women.